Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy.

Herr FL, Dascalescu C, Fusch V, Smith C, Ebner R, Zacherl MJ, Eckenweber F, Klimek K, Auernhammer CJ, Spitzweg C, Ricke J, Heimer MM, Cyran CC, Werner RA, Sheikh GT

Open source

DOI: 10.1186/s13550-025-01305-8
Published: 2025 Aug 21
Container: EJNMMI research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13550-025-01305-8,
  title = {Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy.},
  author = {Herr FL and Dascalescu C and Fusch V and Smith C and Ebner R and Zacherl MJ and Eckenweber F and Klimek K and Auernhammer CJ and Spitzweg C and Ricke J and Heimer MM and Cyran CC and Werner RA and Sheikh GT},
  year = {2025},
  journal = {EJNMMI research},
  doi = {10.1186/s13550-025-01305-8},
  url = {https://doi.org/10.1186/s13550-025-01305-8}
}

RIS

TY  - JOUR
TI  - Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy.
AU  - Herr FL
AU  - Dascalescu C
AU  - Fusch V
AU  - Smith C
AU  - Ebner R
AU  - Zacherl MJ
AU  - Eckenweber F
AU  - Klimek K
AU  - Auernhammer CJ
AU  - Spitzweg C
AU  - Ricke J
AU  - Heimer MM
AU  - Cyran CC
AU  - Werner RA
AU  - Sheikh GT
PY  - 2025
JO  - EJNMMI research
DO  - 10.1186/s13550-025-01305-8
UR  - https://doi.org/10.1186/s13550-025-01305-8
ER  -

APA

FL, H., C, D., V, F., C, S., R, E., MJ, Z., F, E., K, K., CJ, A., C, S., J, R., MM, H., CC, C., RA, W., & GT, S. (2025). Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy.. EJNMMI research. https://doi.org/10.1186/s13550-025-01305-8

Source records

pubmed · retrieved 2026-09-26T11:47:21.522Z